BLFS BIOLIFE SOLUTIONS INC
BIOLIFE SOLUTIONS INC (BLFS) news
BIOLIFE SOLUTIONS INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BLFS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest BIOLIFE SOLUTIONS INC news
We have not published a story on BIOLIFE SOLUTIONS INC yet. When there is news, it will appear here.
BIOLIFE SOLUTIONS INC annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | $7.6 million | $4.8 million |
| Net income (loss) | -$4.6 million | -$20.2 million |
| Cash from operations | $20.1 million | $8.4 million |
| Cash and equivalents | $33.0 million | $91.5 million |
| Short-term investments | $55.9 million | $9.2 million |
Questions about BIOLIFE SOLUTIONS INC
What is the ticker symbol of BIOLIFE SOLUTIONS INC?
BIOLIFE SOLUTIONS INC trades under the ticker BLFS on NASDAQ.
Where is BIOLIFE SOLUTIONS INC listed?
BIOLIFE SOLUTIONS INC is listed on NASDAQ.
Which country or territory is BIOLIFE SOLUTIONS INC listed under?
Our directory records BIOLIFE SOLUTIONS INC under United States.
Does aibio.space cover BIOLIFE SOLUTIONS INC?
aibio.space lists BIOLIFE SOLUTIONS INC among 2,820 public biotech companies and publishes its news here as stories appear.
Is BIOLIFE SOLUTIONS INC profitable?
BIOLIFE SOLUTIONS INC reported a net loss of $4.6 million for the fiscal year ended Dec 31, 2025, and generated $20.1 million of cash from operations, per its annual report to the SEC.
How much does BIOLIFE SOLUTIONS INC spend on research and development?
$7.6 million in the fiscal year ended Dec 31, 2025, per its annual report.
How much cash does BIOLIFE SOLUTIONS INC have?
$82.4 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.
Investor discussion: BIOLIFE SOLUTIONS INC
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Listings
Filed to end its SEC reporting. SEC Form 15-12G. Source
- Listings
Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 2.01,3.01,3.03,5.01,5.02,5.03,5.07,9.01). Source
- Listings
Filed to remove its shares from exchange listing. SEC Form 25-NSE. Source
- Mergers
Reported a merger or acquisition agreement. SEC Form 425. Source
Stock chart
Listing details
- Company
- BIOLIFE SOLUTIONS INC
- Ticker
- BLFS
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio